Gauss Surgical is an investor-backed medical device start-up company in Palo Alto, CA developing a mobile platform for real-time monitoring of fluids and blood loss during surgery. Gauss is leveraging mobile applications, cloud based computing, and artificial intelligence to provide information to better assist the clinician in intraoperative fluid management and blood transfusion.

Key corporate executive responsible for managing global marketing, reimbursement and clinical development strategy for $230M revenue company including strategic planning, clinical applications, marketing communications, public relations, customer site account management, health policy, product management, and channel marketing. Revenues grew from $22.4M in fiscal year 2005 to over $230M in fiscal year 2009 through the creation of an entirely new market for radiosurgery capability.Led successful development and execution of 5 prospective multi-center clinical studies including two prostate cancer studies, two lung cancer studies, and one liver cancer study. Developed strategy for enhancing CyberKnife reimbursement with private payers in United States. Secured coverage with several national and regional carriers.Held direct responsibility for developing all SEC materials, roadshow presentation, and support materials resulting in an IPO that exceeded expectations. The February 2007 public offering was oversubscribed and priced above the range.Introduced direct to patient marketing initiatives through direct response television, print advertising, and online social media. Increased overall CyberKnife treatment volumes and revenues at installed accounts.Initiated work force alignment activities in January 2009 that eliminated client services organization. Developed and executed customer facing mitigation plan to alleviate concerns.Grew marketing team from 10 to 60 people worldwide while opening regional offices located in Paris, Hong Kong, and Tokyo.

Created and managed all aspects of BrainLAB business in North America reporting directly to Chief Executive Officer in Germany.Began as first BrainLAB employee in North America, recruited staff from two people in 1997 to over eighty people in 2001.Grew North American business from less than $1 million in 1997 to over $41 million in 2001. Built, maintained, and motivated sales channel consisting of direct sales and independent agents across North America. Successfully transitioned sales channel from independent agents to direct sales force in the United States.Founded and grew a customer service organization focused on surgical support of all products.Developed operations infrastructure including accounting systems, sales and customer support systems, and human resource functions.Implemented financial reporting and control systems to manage fiscal issues during subsidiary’s rapid growth rate.Initiated and maintained key relationships with banking, insurance, legal, and benefits organizations.

- Product Manager, 1992-1996. Oversaw marketing strategy for Multileaf Collimator and Clinac product lines. Held responsibility for products encompassing $200M in annual sales out of $350M total business. - Engineering Project Manager, 1989-1992. Directed development team of 15 technical professionals. - Senior Mechanical Design Engineer, 1987-1989. Designed mechanical systems of Multileaf Collimator product, now the standard of care cancer treatment device. - Manufacturing Engineer, 1982-1987. Optimized production work flow, creating components, fixtures, and tooling for medical linear accelerators.